Accenture (NYSE: ACN) reported first quarter 2022 earnings results today. Revenues increased 27% year-over-year to $15 billion. Net income attributable…
Caption: iStock Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States.…